Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer

Running, not enrolling · Not applicable

Conditions studied: Solid Neoplasm

In brief

This randomized clinical trial studies a geriatric assessment intervention in predicting chemotherapy toxicity and vulnerabilities (or weakness) in older patients with cancer. Assessing patients' functional status, comorbidities, psychological state, social support, nutritional status, and cognitive function before treatment may help identify vulnerabilities, improve care, and decrease chemotherapy side effects in older patients with cancer.

Key facts

Study ID

NCT02517034

Run by

City of Hope Medical Center

People needed

600

Starts

2015-08-04

Expected to finish

2027-02-02

Last updated by the study team

2026-04-20

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of a solid tumor malignancy (any stage)
• Scheduled to start a new chemotherapy regimen (any line, combination cytotoxic chemotherapy with targeted agents are allowed)
• English, Spanish, and/or Chinese speaking
• Able to provide written informed consent

You may not qualify if…

• Not fluent in English, Spanish and/or Chinese (because not all questionnaires have been validated in other languages)

Where it is running

• City of Hope Medical Center — Duarte, California, United States
• City of Hope Antelope Valley — Lancaster, California, United States
• City of Hope Rancho Cucamonga — Rancho Cucamonga, California, United States
• City of Hope South Pasadena — South Pasadena, California, United States
• City of Hope West Covina — West Covina, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.